Perceptive Advisors LLC Verona Pharma PLC Call Options Transaction History
Perceptive Advisors LLC
- $3.83 Billion
- Q3 2024
Call Options
2 transactions
Others Institutions Holding VRNA
# of Institutions
174Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Nea Management Company, LLC Timonium, MD5.58MShares$329 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$295 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$249 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$209 Million14.95% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$200 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.6B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...